$LOGQ
Coyni, Inc.

2024 Q1 Form 10-Q Financial Statement

#000118518524000528 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $29.53K $275.6K
YoY Change -89.29% 1283.63%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $29.53K $275.6K
YoY Change -89.29% 1283.63%
Operating Profit -$29.53K -$275.6K
YoY Change -89.29% 1283.36%
Interest Expense $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00
YoY Change
Pretax Income -$29.53K -$275.6K
YoY Change -89.29% 177.28%
Income Tax
% Of Pretax Income
Net Earnings -$29.53K -$275.6K
YoY Change -89.29% 177.28%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 -$0.01
Diluted Earnings Per Share $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 101.3M shares 2.302M shares
Diluted Shares Outstanding 40.58M shares

Balance Sheet

Concept 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $0.00
Short-Term Investments
Other Short-Term Assets $1.260K $510.00
YoY Change 147.06% 0.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $1.261K $511.00
YoY Change 146.77% 0.2%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.261K $511.00
Total Long-Term Assets $0.00 $0.00
Total Assets $1.261K $511.00
YoY Change 146.77% 0.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $76.71K $54.93K
YoY Change 39.65% -98.69%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $187.6K $54.93K
YoY Change 241.58% -99.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $187.6K $54.93K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $187.6K $54.93K
YoY Change 241.56% -99.17%
SHAREHOLDERS EQUITY
Retained Earnings -$29.61M -$29.51M
YoY Change 0.35%
Common Stock $101.3K $100.3K
YoY Change 1.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$186.4K -$54.42K
YoY Change
Total Liabilities & Shareholders Equity $1.261K $511.00
YoY Change 146.77% 0.2%

Cashflow Statement

Concept 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$29.53K -$275.6K
YoY Change -89.29% 177.28%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $0.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities $0.00
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash $0.00 $0.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
000-22711
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
COYNI, INC.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
76-0640970
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3131 Camino Del Rio N, Suite 1400
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92108
CY2024Q1 dei City Area Code
CityAreaCode
(855)
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
201-1613
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
101301968 shares
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1261 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2011 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
1261 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
2011 usd
CY2024Q1 us-gaap Assets
Assets
1261 usd
CY2023Q4 us-gaap Assets
Assets
2011 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
76706 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
76706 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
110918 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
82142 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
187624 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
158848 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
9999942 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
9999942 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
101301968 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
101301968 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101301968 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101301968 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
101302 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
101302 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
29321475 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
29321475 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29609140 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29579614 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-186363 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-156837 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1261 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2011 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
221702 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
29526 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
54524 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-29526 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-276226 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
0 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
0 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-29526 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-276226 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101301968 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40581181 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-156837 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-29526 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-186363 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-28451 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-276226 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
221702 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-82975 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-29526 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-276226 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
221702 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-750 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
0 usd
CY2024Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
28776 usd
CY2023Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
54524 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2024Q1 logq Operating Expenses Directly Paid By A Related Party
OperatingExpensesDirectlyPaidByARelatedParty
28776 usd
CY2023Q1 logq Operating Expenses Directly Paid By A Related Party
OperatingExpensesDirectlyPaidByARelatedParty
39423 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration:underline">SIGNIFICANT ESTIMATES</span></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the periods. Actual results could differ from estimates making it reasonably possible that a change in the estimates could occur in the near term.</p>
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-29526 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-276226 usd
CY2024Q1 logq Working Capital Deficit
WorkingCapitalDeficit
-186363 usd
CY2023Q4 logq Working Capital Deficit
WorkingCapitalDeficit
-156837 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-186363 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-156837 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
37283 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
37283 usd
CY2024Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
39423 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
39423 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
76706 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
76706 usd
CY2017Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.34 pure
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21 pure
CY2024Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2366658 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2360457 usd
CY2024Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2366658 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2360457 usd
CY2024Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2024Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
9108809 usd
CY2024Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
2160990 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
98000000 shares
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
221702 usd
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
221702 usd
CY2023Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1000000 shares
CY2023Q2 us-gaap Subsidiary Or Equity Method Investee Cumulative Number Of Shares Issued For All Transactions
SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfSharesIssuedForAllTransactions
99000000 shares
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000768216

Files In Submission

Name View Source Status
0001185185-24-000528-index-headers.html Edgar Link pending
0001185185-24-000528-index.html Edgar Link pending
0001185185-24-000528.txt Edgar Link pending
0001185185-24-000528-xbrl.zip Edgar Link pending
coyni20240331_10q.htm Edgar Link pending
ex_670282.htm Edgar Link pending
ex_670283.htm Edgar Link pending
ex_670284.htm Edgar Link pending
ex_670285.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
logq-20240331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
logq-20240331_cal.xml Edgar Link unprocessable
logq-20240331_def.xml Edgar Link unprocessable
logq-20240331_pre.xml Edgar Link unprocessable
coyni20240331_10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
logq-20240331_lab.xml Edgar Link unprocessable